Back to company

Biotech Force Danmark ApS: Financial statements 2018

CVR: 36434309

Biotech Force Danmark ApS (CVR 36434309) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 3,644,900 and a net result of DKK 1,197,719 compared with DKK -945,456 the year before. That is an increase of 129.4% compared with the year before. Equity amounted to DKK 6,543,280. The solvency ratio was 21.4%.

Gross Profit
3,644,900 kr.
Profit/Loss
1,197,719 kr.
Equity
6,543,280 kr.
Total Assets
30,508,019 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-3.6 mio.1.2 mio.6.5 mio.-
2017-1.6 mio.-945 t.5.3 mio.-
2016-1.3 mio.-378 t.6.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Biotech Force Danmark ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

Biotech Force Danmark ApS: The 2017 annual report is outJun 19, 2018

Biotech Force Danmark ApS has published its annual report for 2017. Gross profit came to DKK 1,589,046, and the net result was DKK -945,456.

About Biotech Force Danmark ApS

Biotech Force Danmark ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2014. The company is registered under the industry Engroshandel med rengøringsmidler. The company was previously named ANTi-COVID 19 Danmark ApS and GL. DONSVEJ 6 KOLDING ApS. The management consists of Jette Kjærgaard. The company's owners include JMR HOLDING, KOLDING A/S, PLAN Invest A/S and Reinert Family Invest ApS. In 2025, the company reported a gross profit of DKK -3,515,065 and a net result of DKK -4,321,793 compared with DKK -2,161,531 the year before. Equity amounted to DKK -18,527,805.